Based on research and analysis about global biomedical market, Frost & Sullivan (Sullivan), one of the biggest business consulting companies, presented “2016 Growth, Innovation and Leadership Awards” to Zensun (Shanghai) Sci. &Tech. Co. Ltd. This award highly recognized all the efforts Zensun has made in Chinese biomedical innovation, as well as all the contributions Zensun’s ground-breaking products have invested to China’s new drug innovation.

As an authoritative global third party selection in biomedical industry, Sullivan presented  the “2016 Growth, Innovation and Leadership Awards” after systematic research and evaluation as well as strict appraisal. This prize is to appreciate Zensun’s innovation in technology, business model, and products. Zensun distinguishes among Chinese biopharmaceutical market by its marketplace, growth potential, product characteristics and competitive advantages. Zensun is also a pioneer of innovative biopharmaceutical research in China and will stay committed to developing original new drugs for global market.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from 40 offices on six continents.